The magnitude of the problem of chronic diseases (NCDs) in India is substantial and is growing

By EP News Bureau on November 7, 2014

Related Posts

Panel Discussion: Why Ahmedabad is a go-to destination for pharma manufacturing?

Prabhat Balyan, Business Development Manager, AMI Polymer

Naresh Gaur, Sr VP – Manufacturing Operations, Amneal Pharma

Sri Harsha V, AVP – BD and Sales, Sigachi Industries

Dr Girisha Patel, Head – Corporate Quality, Corona Remedies

Hiren Rathod, Regional Head – Sales (West & Madhya Pradesh), Optel Group

Sanjay Singh, VP-Operations, Cadila Pharmaceuticals
Comments (0)
Add Comment